<?xml version="1.0" encoding="UTF-8" standalone="yes"?><EventTranscript id="787437"><Name>Interim 2003 SkyePharma PLC Earnings Conference Call</Name><Company>SkyePharma plc</Company><Drugs><Drug>morphine (controlled release, DepoFoam), Pacira</Drug><Drug>ramipril (controlled release, Geomatrix), King</Drug><Drug>alfuzosin (oral, once-daily, GEOMATRIX), Sanofi</Drug><Drug>paroxetine hydrochloride hemihydrate (controlled release, GEOMATRIX), GlaxoSmithKline</Drug><Drug>AS-210</Drug><Drug>ropinirole</Drug><Drug>cytarabine (sustained release, DepoFoam), Pacira/Sigma-Tau/Pfizer/Napp Pharmaceutical</Drug><Drug>alfuzosin</Drug><Drug>paroxetine hydrochloride hemihydrate</Drug><Drug>bupivacaine (extended release/DepoFoam, postoperative pain), Pacira Pharmaceuticals/Maruho</Drug><Drug>formoterol</Drug><Drug>diclofenac (gel, actinic keratosis), SkyePharma</Drug></Drugs></EventTranscript>